Emeritus Corpwa Receivables Turnover Ratio (ESC), from the first quarter 2014 to the first quarter 2013 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Emeritus Corpwa  (ESC)
 

Emerituswa Accounts Receivables Turnover Ratio from the first quarter 2014 to the first quarter 2013

Quarterly Results, Trends, Rankings, Statistics


Emeritus Corpwa's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the first quarter 2014 to a ratio of 30.43, this represents a new company high. This is a clear indication for improving liquidity at Emeritus Corpwa's clients. Average receivable collection period, for the Emerituswa in Mar 31 2014 quarter, has decreased to 12 days, compared to 13 days, in the Dec 31 2013 quarter.

If we take a look into Healthcare sector 16 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 375, from overall ranking in the fourth quarter 2013 at 2095.

What is Receivable Turnover Ratio?
What is Emeritus Corpwa Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ESC Receivables Turnover Ratio (Mar 31 2014)
I. Quarter		 (Dec 31 2013)
IV. Quarter		 (Sep 30 2013)
III. Quarter		 (Jun 30 2013)
II. Quarter		 (Mar 31 2013)
I. Quarter
Y / Y Receivable Change -13.19 % -30.22 % 40.69 % 59.34 % 78.58 %
Y / Y Revenue Change 10.47 % 18.98 % 29.02 % 26.98 % 46.25 %
Receivable Turnover Ratio (TTM) 30.43 28.55 24.84 24.96 25.73
ESC's Total Ranking # 375 # 2095 # 339 # 1899 #
Accounts Receivable average collection period days 12 13 15 15 14
Seq. Receivable Change 7.54 % -3.76 % 2.69 % -18.33 % -13.55 %
Seq. Revenue Change 0.24 % 5.87 % 3.32 % 0.75 % 7.95 %


Receivable Turnover Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 2
Healthcare Sector # 17
Overall Market # 375

Receivable Turnover Ratio Statistics
High Average Low
30.43 28.27 27.2
(Mar 31 2014)   (Sep 30 2013)





ESC Company Profile • Back to ESC Efficiency Comparisons • Compare ESC Receivables Turnover Ratio to its Competitors

Financial Statements
Emerituswa's Accounts Receivable $ 69 Millions Visit ESC's Balance sheet
Emerituswa's Sales TTM $ 2,010 Millions Visit ESC's Income Statement
Sources of ESC's Revenues Visit ESC's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ESC's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ESC's Growth Rates ESC's Roa ESC's Inventory Turnover Ratio ESC's Dividend Comparisons
ESC's Profitability Ratios ESC's Roi ESC's Asset Turnover Ratio ESC's Dividend Growth
ESC's Valuation Ratios ESC's Roe ESC's Financial Strength Ratios ESC's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2014, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Mar 31 2014 Receivable at quarter ending Mar 31 2014
Sonida Senior Living Inc   73.82 $ 355.994  Millions$ 4.823  Millions
Cti Biopharma Corp   67.89 $ 34.963  Millions$ 0.515  Millions
Prothena Corporation Public Limited Company  60.60 $ 32.739  Millions$ 0.540  Millions
Agenus Inc  51.90 $ 2.657  Millions$ 0.051  Millions
United Health Products Inc   47.32 $ 0.097  Millions$ 0.002  Millions
Nektar Therapeutics  39.69 $ 145.688  Millions$ 3.671  Millions
Emeritus Corpwa  36.50 $ 2,010.080  Millions$ 55.071  Millions
Nature s Sunshine Products inc   35.97 $ 375.150  Millions$ 10.429  Millions
Ernexa Therapeutics Inc   34.77 $ 24.051  Millions$ 0.692  Millions
Achari Ventures Holdings Corp I  34.66 $ 162.445  Millions$ 4.687  Millions
Macrogenics Inc   30.78 $ 62.156  Millions$ 2.019  Millions
Veracyte Inc   30.55 $ 24.976  Millions$ 0.818  Millions
Wearable Health Solutions, Inc.  29.33 $ 0.877  Millions$ 0.030  Millions
Interpace Biosciences Inc   29.05 $ 152.612  Millions$ 5.254  Millions
Cba Florida Inc   28.78 $ 5.938  Millions$ 0.206  Millions
Cybrdi, Inc.  28.49 $ 0.572  Millions$ 0.020  Millions
Alnylam Pharmaceuticals Inc   28.23 $ 38.683  Millions$ 1.370  Millions
Brookdale Senior Living Inc   27.37 $ 2,926.975  Millions$ 106.922  Millions
Cyteir Therapeutics Inc   26.30 $ 1,946.600  Millions$ 74.025  Millions
Harrow Inc   25.28 $ 0.009  Millions$ 0.000  Millions
Regulus Therapeutics Inc   25.19 $ 17.962  Millions$ 0.713  Millions
Immunogen inc   24.05 $ 57.984  Millions$ 2.411  Millions
Integrated Biopharma Inc  23.15 $ 49.933  Millions$ 2.157  Millions
Chimerix Inc   22.16 $ 3.379  Millions$ 0.152  Millions
Adma Biologics Inc   21.53 $ 5.686  Millions$ 0.264  Millions
Innoviva Inc   20.88 $ 3.404  Millions$ 0.163  Millions
Windtree Therapeutics Inc  20.72 $ 0.347  Millions$ 0.017  Millions
Sunlink Health Systems Inc   19.95 $ 108.170  Millions$ 5.423  Millions
Oragenics Inc   19.84 $ 1.070  Millions$ 0.054  Millions
Cytocore Inc  19.77 $ 8.026  Millions$ 0.406  Millions

Date modified: 2026-10-15T05:23:19+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.